论文部分内容阅读
藻酸双酯钠(pss)是一种新的类肝素药物,经动物实验及正常人体验证,具有抗凝血、降低血粘度、降低血脂及改善微循环作用,并有明显的红细胞解聚能力;抗凝效价约为肝素的1/3,抗凝持续的时间与肝素相同。动物实验及临床观察朱发现毒副反应。本组共治疗缺血性脑血管病288例,总有效率为92％,总显效率62.2％,与对照组相比有极显著性差异(P<0.005)。实验研究及临床应用表明pss对防治缺血性血管病有重要价值。
Sodium alginate (pss) is a new class of heparinoid drugs, animal experiments and normal human authentication, with anti-coagulation, reduce blood viscosity, reduce blood lipids and improve microcirculation, and significant red blood cell depolymerization ; Anticoagulant titer of about 1/3 of heparin, anticoagulant duration and heparin the same. Animal experiments and clinical observation Zhu found toxic and side effects. This group of 288 cases of ischemic cerebrovascular disease, the total effective rate was 92%, the total effective rate was 62.2%, compared with the control group had a very significant difference (P <0.005). Experimental research and clinical applications show that pss is of great value in the prevention and treatment of ischemic vascular disease.